To Evaluate the Efficacy and Safety of Secondary Prophylaxis of CMV Reactivation
1 clinical trials · Condition
◉ Watch To Evaluate the Efficacy and Safety of Secondary Prophylaxis of CMV Reactivation
| Record | Firm | Date |
|---|---|---|
| Secondary Prophylaxis of CMV Infection Using Letermovir After HID-HSCT (NCT05914701) | Institute of Hematology & Blood Diseases Hospital, China | 2023-07-01 |
Track To Evaluate the Efficacy and Safety of Secondary Prophylaxis of CMV Reactivation automatically
Every clearance here is in the API, with alerts when new ones post.